camptothecin has been researched along with cetyltrimethylammonium ion in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Commes, T; Hammers, H; Kachhap, SK; Kaelber, NS; Kant, H; Kim, E; Liu, JO; Mendonca, J; Shim, JS; Van Diest, PJ; Wissing, MD | 1 |
1 other study(ies) available for camptothecin and cetyltrimethylammonium ion
Article | Year |
---|---|
Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Cycle Proteins; Cell Growth Processes; Cell Line, Tumor; Cetrimonium; Cetrimonium Compounds; Gene Knockdown Techniques; Humans; Intracellular Signaling Peptides and Proteins; Irinotecan; Male; Middle Aged; Prostatic Neoplasms; RNA, Small Interfering; Surface-Active Agents | 2013 |